Exablate Neuro receives CE markFebruary 4, 2019
Exablate Neuro compatible with Magnetom Skyra and Prisma Fit scanners from Siemens Healthineers received CE mark. Exablate Neuro uses focused ultrasound for treatments deep within the brain with no surgical incisions. MR imaging provides a complete anatomical survey of the treatment area, patient-specific planning and real-time outcome monitoring throughout the treatment.
The CE mark includes approval for treatment of medication-refractory essential tremor, tremor-dominant Parkinson’s disease and neuropathic pain. FDA approval for the Exablate Neuro compatibility with MRI scanners from Siemens Healthineers to treat medication-refractory essential tremor was received on October 1, 2018.
Clínica Universidad de Navarra (CUN) in Pamplona, Spain is the first institution in Europe to successfully treat patients with Exablate Neuro compatible with MRI scanners from Siemens Healthineers. CUN is a renowned academic institution with a history of innovative research and clinical treatment for neurological movement disorders.